Follow
Laura Judith Marcos-Zambrano (ORCID: 0000-0003-1381-6407)
Laura Judith Marcos-Zambrano (ORCID: 0000-0003-1381-6407)
Posdoctoral Researcher, IMDEA Food
Verified email at imdea.org
Title
Cited by
Cited by
Year
Applications of machine learning in human microbiome studies: a review on feature selection, biomarker identification, disease prediction and treatment
LJ Marcos-Zambrano, K Karaduzovic-Hadziabdic, T Loncar Turukalo, ...
Frontiers in microbiology 12, 634511, 2021
2152021
Production of biofilm by Candida and non-Candida spp. isolates causing fungemia: comparison of biomass production and metabolic activity and development of cut-off points
LJ Marcos-Zambrano, P Escribano, E Bouza, J Guinea
International Journal of Medical Microbiology 304 (8), 1192-1198, 2014
1632014
Antifungal resistance to fluconazole and echinocandins is not emerging in yeast isolates causing fungemia in a Spanish tertiary care center
LJ Marcos-Zambrano, P Escribano, C Sánchez, P Muñoz, E Bouza, ...
Antimicrobial agents and chemotherapy 58 (8), 4565-4572, 2014
592014
Statistical and machine learning techniques in human microbiome studies: contemporary challenges and solutions
I Moreno-Indias, L Lahti, M Nedyalkova, I Elbere, G Roshchupkin, ...
Frontiers in microbiology 12, 635781, 2021
572021
Candida guilliermondii complex is characterized by high antifungal resistance but low mortality in 22 cases of candidemia
LJ Marcos-Zambrano, M Puig-Asensio, F Pérez-García, P Escribano, ...
Antimicrobial agents and chemotherapy 61 (7), 10.1128/aac. 00099-17, 2017
542017
The novel oral glucan synthase inhibitor SCY-078 shows in vitro activity against sessile and planktonic Candida spp.
LJ Marcos-Zambrano, M Gómez-Perosanz, P Escribano, E Bouza, ...
Journal of Antimicrobial Chemotherapy 72 (7), 1969-1976, 2017
382017
Multicentre determination of rezafungin (CD101) susceptibility of Candida species by the EUCAST method
MC Arendrup, J Meletiadis, O Zaragoza, KM Jørgensen, ...
Clinical Microbiology and Infection 24 (11), 1200-1204, 2018
342018
Scope and frequency of fluconazole trailing assessed using EUCAST in invasive Candida spp. isolates
LJ Marcos-Zambrano, P Escribano, C Sánchez-Carrillo, E Bouza, ...
Medical Mycology 54 (7), 733-739, 2016
312016
Comparison of the antifungal activity of micafungin and amphotericin B against Candida tropicalis biofilms
LJ Marcos-Zambrano, P Escribano, E Bouza, J Guinea
Journal of Antimicrobial Chemotherapy 71 (9), 2498-2501, 2016
302016
In Vitro Exposure to Increasing Micafungin Concentrations Easily Promotes Echinocandin Resistance in Candida glabrata Isolates
MÁ Bordallo-Cardona, P Escribano, EGG de la Pedrosa, ...
Antimicrobial Agents and Chemotherapy 61 (2), 10.1128/aac. 01542-16, 2017
292017
Therapeutic drug monitoring of voriconazole helps to decrease the percentage of patients with off-target trough serum levels
J Guinea, P Escribano, LJ Marcos-Zambrano, T Peláez, M Kestler, ...
Sabouraudia 54 (4), 353-360, 2016
272016
Sputum and bronchial secretion samples are equally useful as bronchoalveolar lavage samples for the diagnosis of invasive pulmonary aspergillosis in selected patients
P Escribano, LJ Marcos-Zambrano, T Peláez, P Muñoz, B Padilla, ...
Medical mycology 53 (3), 235-240, 2015
242015
Persistent Candidemia in adults: underlying causes and clinical significance in the antifungal stewardship era
C Agnelli, M Valerio, E Bouza, A Vena, J Guinea, ...
European Journal of Clinical Microbiology & Infectious Diseases 38, 607-614, 2019
222019
Is biofilm production a prognostic marker in adults with candidaemia?
P Muñoz, C Agnelli, J Guinea, A Vena, A Álvarez-Uría, ...
Clinical Microbiology and Infection 24 (9), 1010-1015, 2018
222018
Candida isolates causing candidemia show different degrees of virulence in Galleria mellonella
LJ Marcos-Zambrano, MÁ Bordallo-Cardona, E Borghi, M Falleni, D Tosi, ...
Medical mycology 58 (1), 83-92, 2020
212020
Biofilm production and antibiofilm activity of echinocandins and liposomal amphotericin B in echinocandin-resistant yeast species
LJ Marcos-Zambrano, M Gómez-Perosanz, P Escribano, O Zaragoza, ...
Antimicrobial Agents and Chemotherapy 60 (6), 3579-3586, 2016
212016
Is biofilm production a predictor of catheter-related candidemia?
M Guembe, J Guinea, L Marcos-Zambrano, A Fernandez-Cruz, T Pelaez, ...
Sabouraudia 52 (4), 407-410, 2014
212014
Mutant prevention concentration and mutant selection window of micafungin and anidulafungin in clinical Candida glabrata isolates
MÁ Bordallo-Cardona, LJ Marcos-Zambrano, C Sánchez-Carrillo, ...
Antimicrobial Agents and Chemotherapy 62 (3), 10.1128/aac. 01982-17, 2018
192018
Susceptibility of Candida albicans biofilms to caspofungin and anidulafungin is not affected by metabolic activity or biomass production
LJ Marcos-Zambrano, P Escribano, E Bouza, J Guinea
Sabouraudia 54 (2), 155-161, 2015
192015
Micafungin is more active against Candida albicans biofilms with high metabolic activity
LJ Marcos-Zambrano, P Escribano, M González del Vecchio, E Bouza, ...
Journal of Antimicrobial Chemotherapy 69 (11), 2984-2987, 2014
192014
The system can't perform the operation now. Try again later.
Articles 1–20